An immunological and genetic study of patients with gestational diabetes mellitus

Acta Diabetologica

Volumn 33, Issue 2, 1996, Pages 139-144

  Lapolla, A ^a   Betterle, C ^a   Sanzari, M ^a   Zanchetta, R ^a   Pfeifer, E ^a   Businaro, A ^a   Fagiolo, U ^a   Plebani, M ^a   Marini, S ^a   Photiou, E ^a   Fedele, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Autoimmunity; Gestational diabetes mellitus; Histocompatibility antigens; Lymphocyte subsets

Indexed keywords

CD3 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; ETIOLOGY; FEMALE; GENETICS; HLA TYPING; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NORMAL HUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 9444234555     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00569424     Document Type: Article

References (42)

1. Metzger BE, and The Organizing Committee, Summary and recommendation of the Third International Workshop Conference on Gestational Diabetes Mellitus. Diabetes 40 (Suppl 2): 107-201, 1991
2. Kuhl C, Hornnes PJ, Andersen O, Etiology and pathophysiology of gestational diabetes mellitus. Diabetes 34 (Suppl 2): 66-70, 1985
3. Damm PD, Molsted-Pedersen L, Kuhl CK, High incidence of diabetes mellitus and impaired glucose tolerance in women with previous gestational diabetes mellitus. Diabetologia 32: 479-482, 1989
4. O'Sullivan JB, Diabetes mellitus after GDM. Diabetes 29 (Suppl 2):131-135, 1991
5. Sepe SJ, Connel FA, Geiss LS, Teutsch SM, Gestational diabetes: incidence, maternal characteristics and perinatal outcome. Diabetes 34 (Suppl 2):13-16, 1985
6. Van Assche FA, Aerts L, Holemans K, Metabolic alterations in adulthood after intrauterine development in mothers with mild diabetes. Diabetes 40 (Suppl 2):106-108, 1991
7. Ginsberg-Fellner F, Mark EM, Nechemias C, Hausknecht RU, Rubinstein P, Dobersen MJ, Notkins AL, Islet cell antibodies in gestational diabetics. Lancet 2:362-363, 1980
8. Hare JW, White P, Gestational diabetes and the White classification Diabetes Care 3 (Suppl 2):394, 1980
9. Rubinstein P, Walker M, Krassner J, Carrier C, Carpenter C, Doberson MJ, Notkins AL, Mark EM, Nechemias C, Hausknecht RU, Ginsberg-Fellner F, HLA antigens and islet cell antibodies in gestational diabetes. Hum Immunol 3:271-275, 1981
10. Stowers JM, Sutherland HW, Kerridge DF, Long-range implications for the mother. The Aberdeen experience. Diabetes 34 (Suppl 2):106-110, 1985
11. Freinkel N, Metzger BE, Phelps RL, Dooley SL, Ogata ES, Radvany RM, Belton A, Gestational diabetes mellitus - heterogeneity of maternal age, weight, insulin secretion. HLA antigens and islet cell antibodies, and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring. Diabetes 34 (Suppl 2): 1-7, 1985
12. Owerbach D, Carnegie S, Rich C, Metger BE, Freinkel N, Gestational diabetes mellitus is associated with HLA-DQ-β-chain DNA endonuclease fragments. Diabetes Research 6: 109-112, 1987
13. Mauricio D, Corcoy RM, Codina M, Balsells M, Puig-Domingo M, Pou JM, De Leiva A, Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes mellitus shortly after pregnancy. Diabetes Nutr Metab 5:237-241, 1992
14. Catalano PM, Tyzbir ED, Sims EAH, Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13:478-482, 1990
15. Fallucca F, Di Mario U, Gargiulo P, Iavicoli M, Galfo C, Contreas G, Pachi A, Andreani D, Humoral immunity in diabetic pregnancy: interrelationships with maternal/neonatal complications and maternal metabolic control. Diabete Metabol 11:386-395, 1985
16. Steel JM, Irvine WJ, Clarke BF, The significance of pancreatic islet cell antibody and abnormal glucose tolerance during pregnancy J Clin Lab Immunol 4: 83-85, 1980
17. Ziegler AG, Hillebrand B, Rabl W, Mayrhofer M, Hummel M, Mollenhauer U, Vordemann J, Lenz A, Standl E, On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia 36:402-408, 1980
18. McEvoy RC, Franklin B, Ginsberg-Fellner F, Gestational diabetes mellitus: evidence for autoimmunity against the pancreatic β cells. Diabetologia 34:507-510, 1991
19. Aguade LCM, Dib SA, Schirmer U, Russo EMK, Camano L, Chacra SR, Bertini AM, Islet-cell antibodies (ICA) and insulin autoantibodies (IAA) and post/partum follow-up of patients with gestational diabetes mellitus and their offsprings. First Inter-national Symposium on Diabetes and Pregnancy in the 90's, Israel, March 1992, 77
20. Jovanovic-Peterson L, Kitzmiller JL, Peterson CM, Randomized trial of human versus animal species insulin in diabetic pregnant women: improved glycemic control, not fewer antibodies to insulin, influences birth weight. Am J Obstet Gynecol 167 1325-1330, 1992
21. Di Mario U, Dotta F, Gargiulo P, Sutherland J, Andreani D, Guy K, Pachi A, Fallucca F, Immunology in diabetic pregnancy: activated T cells in diabetic mothers and neonates. Diabetologia 30:66-71, 1987
22. Bompiani GD, Galluzzo A, Giordano C, Botta RM, T lymphocyte subset phenotypes in diabetic pregnant women and their infants. In: Immunology in Diabetes '84 International Symposium, Rome, 15-17 March 1984, 15
23. Garrow JS, Treat obesity seriously. A clinical manual. Churchill Livingstone, Edinburgh. 1981
24. Tanner JM, Whitehouse RH, Clinical longitudinal standards for height, weight, height velocity, weight velocity and the stages of puberty. Arch Dis Child 51: 170-179, 1976
25. Lapolla A, Mazzon S, Marini S, Burattin G, Grella P, Fedele D, A screening programme for gestational diabetes in a north Mediterranean area. Diabetes Nutr Metab 8:33-41, 1995
26. Carpenter MW, Coustan DR, Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768-773, 1982
27. Jovanovic L, Peterson CM, Screening for gestational diabetes: optimum timing criteria for retesting. Diabetes 34 (Suppl 2): 21-23, 1985
28. O'Sullivan JB, Harris MI, Mills JL, Maternal diabetes in pregnancy. In: Harris MI, Hammon RF (eds) Diabetes in America. Diabetes Data Compiled 1984, Washington DC. pp 1-17, 1985
29. Huggett AST, Nixon DA, Use of glucose oxidase peroxidase and O-dianisine in the determination of blood and urine glucose. Lancet 2: 368-370, 1957
30. 1c by high performance cation exchange chromatography. Clin Chem 26: 466-470, 1980
31. Bonifacio E, Boitard C, Gleichmann H, Shattock MA, Molenaar JL, Bottazzo GF, Betterle C et al., Assessment of precision, concordance, specificity and sensitivity of islet eel! antibody measurement in 41 assays. Diabetologia 33:731-736, 1990
32. Betterle C, Presotto F, Pedini B, Moro L, Slack RS, Zanette F, Zanchetta R, Islet cell and insulin autoantibodies in organspecific autoimmune patients. Their behaviour and predictive value in the development of type 1 (insulin-dependent) diabetes mellitus. A ten years follow-up study. Diabetologia 30:292-297, 1987
33. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus, and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
34. Greenbaum CJ, Palmer JP, Kuglin B, Kolb H and participating laboratories, Insulin autoantibodies measured by RIA methodology are more related to IDDM than those measured by ELISA on the standardisation of insulin autoantibodies measurement. J Clin Endocrinol Metab 5:1040-1044, 1992
35. Betterle C, Callegari G, Presotto F, Zanette F, Pedini B, Rampazzo T, Slaek RS, Girelli ME, Busnardo B, Thyroid autoantibodies: a good marker for the study of symptomless autoimmune thyroiditis. Acta Endocrinol (Copenh) 114:321-327, 1987
36. Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F, Mantero F, The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 117:467-475, 1988
37. Vitale M, Papa S, Mariani AR, Facchin A, Rizzoli R, Manzoli FA, Use of polygonal windows for physical discrimination among mononuclear subpopulation in flow cytometry. J Immunol Methods 96:63-68, 1987
38. Lowry R, Goguen J, Carpenter CB, Strom TB, Garovoy MR, Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparation. Tissue Antigens 14:325-331, 1979
39. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth G, Lifetable analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with Type 1 diabetes. Diabetes 38-1320-1325, 1989
40. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M, A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 320:881-886, 1989
41. Palmer JP, Predicting IDDM. Use of humoral immune markers. Diabetes Rev 1:104-105, 1993
42. Betterle C, Zanette F, Pedini B, Presotto F, Rapp LM, Monciotti CM, Rigon F, Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and in their first degree relatives. Diabetologia 26:431-436, 1984